57890253_HM5025_0000281BDL.tumor.abra.bam

syn18145258

Created By Matt msoloway

species: Homo sapiens
studyId: syn51133946
studyName: DHART SPORE Project 3 - A High Content Clinical Trial (ADVL1521) of the MEK Inhibitor Trametinib in Juvenile Myelomonocytic Leukemia (JMML), a Phase II clinical trial
accessType: PRIVATE
fileFormat: bam
initiative: DHART-SPORE Project 3
isCellLine: No
dataSubtype: raw
individualID: HM5025
resourceType: experimentalData
fundingAgency: NIH-NCI
isMultiSpecimen: No
isMultiIndividual: No

57890253_HM5025_0000281BDL.tumor.abra.bam page is loading…